Recapitalization - Schedule of Net current assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2022 |
Sep. 16, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|---|---|
| Cash and cash equivalents | $ 167,467 | $ 92,302 | $ 173,984 | |
| Marketable securities | $ 34,837 | $ 38,067 | ||
| Tyme Therapeutics, Inc. | ||||
| Cash and cash equivalents | $ 14,898 | |||
| Marketable securities | 52,220 | |||
| Prepaid expenses | 1,350 | |||
| Total | $ 68,468 |
| X | ||||||||||
- Definition Net assets current. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of investment in marketable security, classified as current. No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|